This is a rare genetic condition present from birth. It causes a specific pattern of skin changes, nail problems, and white patches inside the mouth. It can also lead to an increased risk of certain cancers and problems with blood cell production.
Every report comes from a Lived member, sent anonymously.
Have you had Stem Cell Transplant for Dyskeratosis Congenita?
Dyskeratosis congenita (DC) is a rare inherited condition in which the body cannot properly maintain telomeres, the protective caps on the ends of chromosomes. Cells that divide often are affected most, including those in the bone marrow, skin, nails and the lining of the mouth. The classic signs form a triad: nails that grow poorly or are ridged and misshapen, a lacy, net-like pattern of darker skin on the neck and upper chest, and white patches inside the mouth (oral leukoplakia). Not everyone has all three. The visible signs are usually not the main health concern. People with DC have a much higher risk of bone marrow failure, in which the marrow stops making enough red cells, white cells and platelets. They are also more likely to develop myelodysplastic syndrome (MDS, a disorder of immature blood cells that can turn into leukemia), leukemia itself, certain cancers (especially of the head and neck and the anal and genital areas) and pulmonary fibrosis, a scarring of the lungs that makes breathing harder. Other possible problems include blocked tear ducts and eyelid irritation, dental changes, early graying or hair loss, liver disease, thin bones and damage to the hip or shoulder joints. DC is now seen as the classic end of a broader group called telomere biology disorders. Severity varies widely. Some people have only a few mild signs and normal blood counts, while others develop marrow failure, cancer or lung scarring by early adulthood. Rare severe forms, such as Hoyeraal Hreidarsson syndrome, can also affect brain development. DC is estimated to affect about 1 in a million people.
DC is genetic. It is caused by changes (variants) in genes that build or protect telomeres; at least 16 such genes are known. When telomeres become too short, rapidly dividing cells stop dividing or die, which is why the marrow, skin, nails and mouth lining are affected. Unstable chromosome ends can also lead to genetic damage that allows cancer to develop. How DC passes through a family depends on the gene. The form caused by the DKC1 gene is X-linked, so it mainly affects males, and a father cannot pass it to his sons. Other forms are autosomal dominant, where one altered copy from either parent is enough, or autosomal recessive, where a child inherits an altered copy from each parent. Parents who carry one altered copy often have no symptoms, though for some genes a carrier parent can develop milder problems later. Some cases appear for the first time in a family. In about one in five people with the typical picture, no known gene change is found. Nothing a person does causes DC.
Diagnosis often begins when a clinician notices the nail, skin and mouth triad, or when someone has unexplained low blood counts, early lung scarring or relatives with these problems. Because the features vary and can appear one at a time, DC is easy to miss unless someone suspects it. The key test measures telomere length in white blood cells, using a specialized lab method that tags telomeres with fluorescent markers. Most people with DC have telomeres much shorter than expected for their age. Genetic testing then looks for a variant in the known telomere genes and finds one in about 80% of people who meet the clinical criteria. Some people have no identifiable gene change, so the telomere result and the overall picture still count when the gene test is negative. After diagnosis, baseline checks look at the organs DC can affect: a complete blood count and usually a bone marrow exam, lung function tests, and skin, mouth and dental exams. Relatives with suggestive signs, and anyone being considered as a stem cell donor, should also be tested, because a relative can carry the condition without knowing it.
There is no single treatment for DC as a whole. Care targets the complications a person actually develops and is usually led by a hematologist (blood specialist) with experience in inherited marrow failure, working with other specialists. For bone marrow failure or leukemia, a stem cell transplant (hematopoietic cell transplantation, which replaces the person's marrow with donor cells) is the only treatment that can cure the blood problem. It is a serious decision: people with DC have historically had high rates of transplant complications, and experienced centers use preparation regimens adapted to the condition. When transplant is not possible or no suitable donor is available, androgens (synthetic male hormones such as danazol or oxymetholone) can raise blood counts in some people. In a National Institutes of Health study of danazol in telomere diseases, most people who could be assessed had improved blood counts, though the study was small and had no comparison group. The main trade-offs are liver effects, including tumors and blood-filled cysts with long-term use, which is why people taking androgens have regular blood tests and liver ultrasounds, and masculinizing effects that may be permanent, which matters especially for women and children. They should not be combined with granulocyte colony-stimulating factor, a medicine that boosts white cells, because the combination has been linked to rupture of the spleen. When transfusions are needed, filtered and irradiated blood products are used. There is no cure for pulmonary fibrosis; care focuses on symptoms and may include oxygen and pulmonary rehabilitation, with lung transplant considered for some people. Cancers are treated according to their type, but people with DC often tolerate standard chemotherapy and radiation poorly, with a higher risk of prolonged low blood counts and lung and liver damage. Any cancer team needs to know about the diagnosis before planning treatment.
DC is lifelong, and its course is hard to predict, even within one family. Some people live for years with mild signs and normal marrow function, while others need intensive treatment in childhood or early adulthood. Cancer risk is a central part of the outlook: one recent review estimated about a threefold higher risk of any cancer than in the general population, with a much higher risk of head and neck cancer, especially in the recessive and X-linked forms. Because serious problems can develop quietly, regular surveillance is the backbone of care. For the blood, expert recommendations include a complete blood count at least yearly (more often if counts are abnormal) and a yearly bone marrow exam. For cancer screening, they include a monthly self-check of the mouth, head and neck, yearly exams by an ear, nose and throat specialist and a dermatologist, and a yearly gynecologic exam. For the lungs and teeth, they include yearly lung function tests, starting at diagnosis or once a child can do them (often around age 8), and dental visits every six months with good oral hygiene. These checks aim to catch marrow changes, early cancers and lung disease while more options remain. Daily choices matter too. Not smoking and limiting sun exposure reduce added cancer risk. If a transplant may be needed later, family members are advised not to donate blood to the person. Genetic counseling helps families understand who else may be affected and what their options are, including testing during pregnancy or before embryo implantation once the family's gene change is known.
Ask about an evaluation for DC if someone has the combination of abnormal nails, lacy skin pigmentation and white mouth patches, or has unexplained low blood counts or lung scarring alongside a family history of similar problems. For someone already diagnosed, contact the care team promptly about signs that blood counts may be falling: unusual tiredness or weakness, easy bruising or bleeding, or frequent infections. If the care team has said that the white cell count or platelets are low, including after a transplant, a fever needs a call to the hematology team right away, without waiting, following the fever plan that team gives. If the team cannot be reached, go for emergency care. Bleeding that will not stop with pressure needs emergency care. With low white cells, an infection can become serious quickly, and prompt antibiotics make a difference. Also report, without waiting for the next scheduled visit, a white or red patch or a sore in the mouth that does not heal within two weeks, a new lump in the neck, or shortness of breath or a dry cough that keeps getting worse.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Dyskeratosis Congenita is like, what's helped you, or ask the community a question.